Q1 2022 Holdings
Filed 2022-05-13 | 69 holdings | $21.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cerus Corp(CERS) | COM | 157085101 | $7.7M | 1,398,400 | 35.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $4.7M | 275,333 | 22.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $4.3M | 573,699 | 20.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $2.5M | 114,004 | 11.6% |
| Codexis Inc(CDXS) | COM | 192005106 | $1.7M | 81,000 | 7.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $386.0K | 30,000 | 1.8% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $27.0K | 300,000 | 0.1% |
| Athira Pharma Inc | COM | 04746L104 | $27.0K | 10,000 | 0.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $18.9K | 308,819 | 0.1% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $14.2K | 443,381 | 0.1% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $11.7K | 425,554 | 0.1% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $10.5K | 2,250,000 | 0.0% |
| Merus N V | COM | N5749R100 | $8.6K | 324,719 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $7.1K | 67,442 | 0.0% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $6.1K | 1,004,399 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $5.4K | 105,368 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $4.5K | 138,843 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $4.4K | 102,497 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $3.8K | 46,122 | 0.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $3.6K | 445,334 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $3.1K | 46,489 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $3.1K | 645,000 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $3.1K | 200,494 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $2.9K | 1,207,385 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $2.8K | 68,709 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $2.7K | 14,836 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $2.5K | 41,002 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $2.4K | 102,067 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.3K | 126,136 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $2.3K | 326,872 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $2.3K | 185,666 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $2.0K | 7,638 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $1.9K | 20,482 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $1.8K | 1,032,163 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $1.8K | 101,447 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $1.7K | 436,096 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $1.7K | 248,347 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $1.6K | 204,679 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $1.6K | 174,768 | 0.0% |
| Iveric BIO Inc(OPHTEUR)Put | COM | 46583P102 | $1.6K | 94,600 | 0.0% |
| Aslan Pharmaceuticals LTD | ADS | 04522R101 | $1.6K | 500,000 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $1.6K | 10,956 | 0.0% |
| Immunogen Inc(IMGNEUR)Call | COM | 45253H101 | $1.4K | 300,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.4K | 101,081 | 0.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.4K | 25,000 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $1.4K | 462,659 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $1.3K | 346,405 | 0.0% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $1.3K | 131,151 | 0.0% |
| Amryt Pharma PLC | SPONSORED ADS | 03217L106 | $1.3K | 153,267 | 0.0% |
| Polypid LTD | SHS | M8001Q118 | $1.2K | 218,175 | 0.0% |